Knight Therapeutics Inc.

KHTRF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$4-$17-$30$16
Dep. & Amort.$53$50$63$48
Deferred Tax-$3-$9-$17-$8
Stock-Based Comp.$2$2$2$3
Change in WC-$20-$6-$10$1
Other Non-Cash-$0$15$33-$15
Operating Cash Flow$36$36$40$45
Investing Activities
PP&E Inv.-$2-$1-$26-$224
Net Acquisitions$0$0$0-$220
Inv. Purchases-$163-$334-$185-$64
Inv. Sales/Matur.$211$348$151$181
Other Inv. Act.-$29$17-$2$223
Investing Cash Flow$17$29-$63-$105
Financing Activities
Debt Repay.-$18-$18$31-$14
Stock Issued$0$0$0$0
Stock Repurch.-$9-$53-$30-$64
Dividends Paid$0$0$0$0
Other Fin. Act.-$7-$9-$4$0
Financing Cash Flow-$34-$81$2-$78
Forex Effect$2$3$7-$5
Net Chg. in Cash$21-$13-$14-$144
Supplemental Information
Beg. Cash$59$72$86$230
End Cash$80$59$72$86
Free Cash Flow$5$26$15-$180